- Ongoing, recruitingTherapeutic confirmatory (Phase III)
CMV preemptive therapy in high-risk immunocompetent major heart surgery patients. A multicenter, double blind, randomized, clinical trial (GAN-CAR).
This study looks at preventing serious infections in people having major heart surgery. It tests if certain medicines can stop a common virus called CMV from causing problems after the operation, helping patients recover better.
For: Cytomegalovirus in high-risk immunocompetent major heart surgery.Spain - AuthorisedTherapeutic exploratory (Phase II)
A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients
This study looks at whether adding a drug called valganciclovir to standard treatment can help people with a type of brain tumour called glioblastoma live longer. Doctors are comparing it to a dummy pill to see if it makes a difference.
For: Glioblstoma WHO grade IVSweden · Norway - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)
This study looks at a new drug, nanatinostat, combined with an anti-virus medicine, valganciclovir, for people with specific types of lymphoma that have returned or not responded to previous treatments. It aims to see how well this combination shrinks the cancer.
For: Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory LymphomasSpain · Germany · Italy